Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc.
World Rank (Aug-2026)
5709
Market Cap (Aug-2026)
2.410 Billion USD
Market Cap (Mar-08-2026)
1.531 Billion USD
World Rank (Jan-05-2024)
8,008
Market Cap (Jan-05-2024)
1.123 Billion USD
World Rank (Jul-30-2023)
6,840
Market Cap (Jul-30-2023)
1.514 Billion USD
World Rank (Jan-07-2022)
8,733
Headquarters Country
Nasdaq / NYSE Code
AMLX
Annual Revenue in USD
0 Million USD
Annual Net Income in USD
-145 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
333 Million USD
Total Liabilities in USD
27 Million USD
Total Equity in USD
305 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Company Website
Ads